Latest Regulatory News

American Tungsten & Antimony Ltd (ASX: AT4) has raised A$10 million through a strongly supported placement and secured a 40% Utah state tax credit, underpinning its strategy to develop a domestic US supply chain for tungsten and antimony ahead of a planned Nasdaq listing.

4DMedical’s CT:VQ™ technology has been clinically validated in a top respiratory journal, showing a leap in patient response rates for lung volume reduction surgery from 46% to 76%, promising improved outcomes and hospital efficiencies.

Evergold Minerals has kicked off a 3,000m reverse circulation drilling campaign at its Mt Monger Gold Project, aiming to confirm high-grade gold mineralisation at Duchess of York and test a newly defined intrusive-related target at Gladiator.

Accelerate Resources (ASX: AX8) has doubled its Balagundi Gold Project landholding through a strategic deal with Maritana Minerals (ASX: MRT), acquiring key tenure and receiving $200,000 in shares while divesting non-core Kanowna East assets.

WA Kaolin has successfully recapitalised its balance sheet by approximately A$16.1 million through a partially underwritten entitlement offer and significant debt reduction, positioning the company for operational growth at its Wickepin kaolin project.

Invion Limited has partnered with South Korea's SANGMYUNG Innovation to explore its Photosoft™ photodynamic therapy for wet age-related macular degeneration, addressing a large unmet medical need in ophthalmology.

Bank of Queensland declares a fully franked quarterly distribution of AUD 1.4859 per Capital Note security, reflecting an annualised yield of 5.77%, payable in August 2026.

ClearVue Technologies has secured TÜV SÜD certification for its Thermal Management Junction Box, validating its safety and durability for global BIPV deployment.

Kincora Copper has received a US$1.5 million non-refundable option payment from Tumen Ail Coal, marking a significant step toward divesting its Mongolian subsidiaries. The staged US$10 million deal supports Kincora’s shift to focus on Australian projects and its project generator model.

Strickland Metals (ASX:STK) has confirmed no hidden material information explains recent share price swings, attributing volatility to regulatory delays in Serbia and broader gold sector weakness.

Island Pharmaceuticals has appointed Mark Herzog as Senior Global Health Security Advisor and secured roles in key Medical Countermeasures Coalition groups, boosting its US biodefence engagement ahead of pivotal Galidesivir Animal Rule studies.

Aland Equity Group (ASX: AEG) has locked in long-term funding rights over major NSW and ACT-area developments, marking a strategic pivot into property funds management with a pipeline exceeding 4,200 residential lots and 100,000sqm of commercial space.